The Global Powered Surgical Instrument Market was estimated at $1.9 billion in 2017 and is expected to hit $2.7 billion by 2025, registering a CAGR of 4.2% throughout the forecast period. —
Powered surgical instruments are high-powered specially designed instruments that are used for performing specific or desired actions during a surgery. There are several high-powered surgical drill systems present in the market such as reamer systems, saw systems, stapler, shavers, and other handpieces, which are used during orthopedic, neuro, cardiovascular, cardiothoracic, and various other surgeries.
For more insights into the Market, request a free sample of this report @ https://www.alliedmarketresearch.com/request-sample/5091
The report offers an all-inclusive analysis of the forerunners operating in the global powered surgical instrument market, namely, Conmed Corporation, Medtronic plc, AlloTech Co. Ltd., Stryker Corporation, adeor Medical AG, Smith & Nephew plc, Zimmer Biomet, Depuy Synthes (Johnson & Johnson), MicroAire Surgical Instruments, LLC., B. and Braun Melsungen AG. The other players in the market consist of, De Soutter Medical Ltd., Peter Brasseler Holdings, GEISTER Medizintechnik GmbH, Intrauma S.p.A., Ruijin Medical Instrument & Device Co., Ltd., and LLC,.
Battery-powered instruments segment to portray fastest growth through 2025
The battery-powered instruments segment is expected to register the fastest CAGR of 4.7% during the forecast period. This is attributed to the fact that battery-powered instruments are coreless, lightweight, efficient, and chargeable that provide comfort during surgery, which have boosted their demand. However, electric instruments segment held the largest share in the market in 2017, contributing about 41% of the total revenue, owing to the low cost of electric surgical handpieces and higher power output compared to pneumatic and battery-powered instruments. Pneumatic instruments segment would exhibit steady growth during the forecast period.
Get detailed COVID-19 impact analysis on the Powered Surgical Instrument Market @
Plastic surgery segment to manifest rapid growth by 2025
The plastic surgery segment is estimated to register the fastest CAGR of 6.2% from 2017 to 2023, owing to the growing demand for cosmetic surgeries, increasing incidence of cancer, and growing age-related surgeries across the globe. However, the orthopedic surgery segment accounted the largest share, contributing about 21% share of the market, owing to increased demand for minimally invasive surgery in orthopedics and rise in geriatric population. The other segments analyzed in the report include neurosurgery, ENT surgery, cardiovascular surgery, cardiothoracic surgery, and others.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5091
North America governs the market in 2017
North America held the largest share in the global powered surgical instrument market, garnering about half of the total revenue in 2017, owing to highly sophisticated healthcare infrastructure and high adoption rate of technologically advanced surgical tools in the region. However, Asia-Pacific region is expected to portray the fastest CAGR of 5.4% during the forecast period, owing to high prevalence of chronic diseases and rise in demand of minimally invasive surgery. The other regions analyzed in the report include Europe and Latin America, Middle East and Africa (LAMEA).
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Release ID: 89031061